25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Devyser Diagnostics AB
Buy, Hold or Sell?

Let's analyze Devyser together

I guess you are interested in Devyser Diagnostics AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Devyser Diagnostics AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Devyser Diagnostics AB

I send you an email if I find something interesting about Devyser Diagnostics AB.

1. Quick Overview

1.1. Quick analysis of Devyser (30 sec.)










1.2. What can you expect buying and holding a share of Devyser? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr21.13
Expected worth in 1 year
kr18.13
How sure are you?
16.7%

+ What do you gain per year?

Total Gains per Share
kr-2.99
Return On Investment
-2.3%

For what price can you sell your share?

Current Price per Share
kr129.00
Expected price per share
kr116.00 - kr141.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Devyser (5 min.)




Live pricePrice per Share (EOD)
kr129.00

2.2. Growth of Devyser (5 min.)




Is Devyser growing?

Current yearPrevious yearGrowGrow %
How rich?$31.6m$37.2m-$3.8m-11.4%

How much money is Devyser making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$1.2m-$323k-20.0%
Net Profit Margin-35.9%-37.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Devyser (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Devyser?

Welcome investor! Devyser's management wants to use your money to grow the business. In return you get a share of Devyser.

First you should know what it really means to hold a share of Devyser. And how you can make/lose money.

Speculation

The Price per Share of Devyser is kr129.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Devyser.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Devyser, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr21.13. Based on the TTM, the Book Value Change Per Share is kr-0.75 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.67 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Devyser.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.13-0.1%-0.10-0.1%-0.08-0.1%-0.08-0.1%-0.08-0.1%
Usd Book Value Change Per Share-0.10-0.1%-0.07-0.1%-0.060.0%0.160.1%0.160.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-0.1%-0.07-0.1%-0.060.0%0.160.1%0.160.1%
Usd Price Per Share11.52-9.53-6.47-7.57-7.57-
Price to Earnings Ratio-22.59--25.52--24.82--27.99--27.99-
Price-to-Total Gains Ratio-109.78--171.61--190.04--135.36--135.36-
Price to Book Ratio6.01-4.73-2.87-3.46-3.46-
Price-to-Total Gains Ratio-109.78--171.61--190.04--135.36--135.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.7003
Number of shares85
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.16
Usd Total Gains Per Share-0.070.16
Gains per Quarter (85 shares)-5.7713.57
Gains per Year (85 shares)-23.0754.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-23-3305444
20-46-56010998
30-69-790163152
40-92-1020217206
50-115-1250271260
60-138-1480326314
70-161-1710380368
80-185-1940434422
90-208-2170489476
100-231-2400543530

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.012.00.00.0%0.012.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%0.00.012.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%2.010.00.016.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Devyser Diagnostics AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.157-0.748-35%-0.674-42%1.761-166%1.761-166%
Book Value Per Share--21.12722.340-5%24.878-15%24.699-14%24.699-14%
Current Ratio--4.2104.689-10%7.135-41%8.282-49%8.282-49%
Debt To Asset Ratio--0.2460.2470%0.192+28%0.179+38%0.179+38%
Debt To Equity Ratio--0.3270.3280%0.242+35%0.226+45%0.226+45%
Dividend Per Share----0%-0%-0%-0%
Eps---1.405-1.081-23%-0.865-38%-0.850-40%-0.850-40%
Free Cash Flow Per Share---1.024-1.682+64%-1.522+49%-1.338+31%-1.338+31%
Free Cash Flow To Equity Per Share---1.121-1.591+42%-1.448+29%0.367-405%0.367-405%
Gross Profit Margin--1.0002.667-63%3.129-68%2.266-56%2.266-56%
Market Cap2129764200.000+2%2096744600.0001733941745.000+21%1178469524.000+78%1377715293.667+52%1377715293.667+52%
Net Profit Margin---0.476-0.359-25%-0.377-21%-0.360-24%-0.360-24%
Operating Margin---0.425-0.347-18%-0.444+4%-0.393-8%-0.393-8%
Operating Ratio--1.4251.372+4%1.444-1%1.401+2%1.401+2%
Pb Ratio6.106+2%6.0114.735+27%2.871+109%3.457+74%3.457+74%
Pe Ratio-22.950-2%-22.594-25.516+13%-24.818+10%-27.992+24%-27.992+24%
Price Per Share129.000+2%127.000105.025+21%71.380+78%83.448+52%83.448+52%
Price To Free Cash Flow Ratio-31.505-2%-31.017-17.962-42%-12.486-60%-18.411-41%-18.411-41%
Price To Total Gains Ratio-111.506-2%-109.777-171.610+56%-190.045+73%-135.357+23%-135.357+23%
Quick Ratio--3.5924.085-12%6.735-47%7.837-54%7.837-54%
Return On Assets---0.050-0.037-27%-0.028-43%-0.028-43%-0.028-43%
Return On Equity---0.066-0.049-27%-0.035-48%-0.035-47%-0.035-47%
Total Gains Per Share---1.157-0.748-35%-0.674-42%1.761-166%1.761-166%
Usd Book Value--31636160.00033452427.500-5%37253755.200-15%36985396.575-14%36985396.575-14%
Usd Book Value Change Per Share---0.105-0.068-35%-0.061-42%0.160-166%0.160-166%
Usd Book Value Per Share--1.9162.026-5%2.256-15%2.240-14%2.240-14%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.127-0.098-23%-0.078-38%-0.077-40%-0.077-40%
Usd Free Cash Flow---1532830.000-2519192.500+64%-2278792.150+49%-2003555.442+31%-2003555.442+31%
Usd Free Cash Flow Per Share---0.093-0.153+64%-0.138+49%-0.121+31%-0.121+31%
Usd Free Cash Flow To Equity Per Share---0.102-0.144+42%-0.131+29%0.033-405%0.033-405%
Usd Market Cap193169612.940+2%190174735.220157268516.272+21%106887185.827+78%124958777.136+52%124958777.136+52%
Usd Price Per Share11.700+2%11.5199.526+21%6.474+78%7.569+52%7.569+52%
Usd Profit---2104240.000-1618995.000-23%-1295944.252-38%-1272672.159-40%-1272672.159-40%
Usd Revenue--4417090.0004489650.000-2%3585212.275+23%3575802.150+24%3575802.150+24%
Usd Total Gains Per Share---0.105-0.068-35%-0.061-42%0.160-166%0.160-166%
 EOD+5 -3MRQTTM+12 -22YOY+13 -215Y+9 -2510Y+9 -25

3.3 Fundamental Score

Let's check the fundamental score of Devyser Diagnostics AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-22.950
Price to Book Ratio (EOD)Between0-16.106
Net Profit Margin (MRQ)Greater than0-0.476
Operating Margin (MRQ)Greater than0-0.425
Quick Ratio (MRQ)Greater than13.592
Current Ratio (MRQ)Greater than14.210
Debt to Asset Ratio (MRQ)Less than10.246
Debt to Equity Ratio (MRQ)Less than10.327
Return on Equity (MRQ)Greater than0.15-0.066
Return on Assets (MRQ)Greater than0.05-0.050
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Devyser Diagnostics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.635
Ma 20Greater thanMa 50133.475
Ma 50Greater thanMa 100130.400
Ma 100Greater thanMa 200120.510
OpenGreater thanClose130.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Devyser Diagnostics AB

Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia. The company offers products in the areas of post-transplantation; thalassemia; breast, colorectal, and ovarian cancer; non-invasive fetal RHD screening prenatal testing, hereditary, cystic fibrosis, cardiovascular, male infertility, and rapid aneuploidy analysis, as well as accessories. Its products are used for targeted cancer treatment to diagnosis genetic diseases and transplant patient follow-up. The company also provides software programs for data processing and analysis, as well as interpretation of test results; and Amplicon Suite and Advyser software programs to screen markers and follow up samples for the same patient. Devyser Diagnostics AB (publ) was incorporated in 2004 and is headquartered in Hägersten, Sweden.

Fundamental data was last updated by Penke on 2024-11-14 17:40:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Devyser earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -47.6% means that kr-0.48 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Devyser Diagnostics AB:

  • The MRQ is -47.6%. The company is making a huge loss. -2
  • The TTM is -35.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-47.6%TTM-35.9%-11.7%
TTM-35.9%YOY-37.7%+1.8%
TTM-35.9%5Y-36.0%+0.1%
5Y-36.0%10Y-36.0%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-47.6%-5.6%-42.0%
TTM-35.9%-8.8%-27.1%
YOY-37.7%-0.8%-36.9%
5Y-36.0%-1.9%-34.1%
10Y-36.0%-0.3%-35.7%
4.3.1.2. Return on Assets

Shows how efficient Devyser is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • -5.0% Return on Assets means that Devyser generated kr-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Devyser Diagnostics AB:

  • The MRQ is -5.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.0%TTM-3.7%-1.3%
TTM-3.7%YOY-2.8%-0.8%
TTM-3.7%5Y-2.8%-0.8%
5Y-2.8%10Y-2.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.0%-1.2%-3.8%
TTM-3.7%-2.1%-1.6%
YOY-2.8%-0.9%-1.9%
5Y-2.8%-0.1%-2.7%
10Y-2.8%-0.5%-2.3%
4.3.1.3. Return on Equity

Shows how efficient Devyser is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • -6.6% Return on Equity means Devyser generated kr-0.07 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Devyser Diagnostics AB:

  • The MRQ is -6.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -4.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.6%TTM-4.9%-1.8%
TTM-4.9%YOY-3.5%-1.4%
TTM-4.9%5Y-3.5%-1.4%
5Y-3.5%10Y-3.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.6%-0.4%-6.2%
TTM-4.9%-1.7%-3.2%
YOY-3.5%0.3%-3.8%
5Y-3.5%-0.9%-2.6%
10Y-3.5%-0.9%-2.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Devyser Diagnostics AB.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Devyser is operating .

  • Measures how much profit Devyser makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • An Operating Margin of -42.5% means the company generated kr-0.43  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Devyser Diagnostics AB:

  • The MRQ is -42.5%. The company is operating very inefficient. -2
  • The TTM is -34.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-42.5%TTM-34.7%-7.8%
TTM-34.7%YOY-44.4%+9.7%
TTM-34.7%5Y-39.3%+4.5%
5Y-39.3%10Y-39.3%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-42.5%-9.6%-32.9%
TTM-34.7%-12.4%-22.3%
YOY-44.4%2.6%-47.0%
5Y-39.3%1.4%-40.7%
10Y-39.3%4.1%-43.4%
4.3.2.2. Operating Ratio

Measures how efficient Devyser is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are kr1.43 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Devyser Diagnostics AB:

  • The MRQ is 1.425. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.372. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.425TTM1.372+0.053
TTM1.372YOY1.444-0.072
TTM1.3725Y1.401-0.029
5Y1.40110Y1.4010.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4251.311+0.114
TTM1.3721.294+0.078
YOY1.4441.266+0.178
5Y1.4011.208+0.193
10Y1.4011.191+0.210
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Devyser Diagnostics AB.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Devyser is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 4.21 means the company has kr4.21 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Devyser Diagnostics AB:

  • The MRQ is 4.210. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.689. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.210TTM4.689-0.479
TTM4.689YOY7.135-2.446
TTM4.6895Y8.282-3.593
5Y8.28210Y8.2820.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2102.028+2.182
TTM4.6892.113+2.576
YOY7.1352.555+4.580
5Y8.2822.668+5.614
10Y8.2823.230+5.052
4.4.3.2. Quick Ratio

Measures if Devyser is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • A Quick Ratio of 3.59 means the company can pay off kr3.59 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Devyser Diagnostics AB:

  • The MRQ is 3.592. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.085. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.592TTM4.085-0.493
TTM4.085YOY6.735-2.650
TTM4.0855Y7.837-3.752
5Y7.83710Y7.8370.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5921.206+2.386
TTM4.0851.241+2.844
YOY6.7351.685+5.050
5Y7.8372.100+5.737
10Y7.8372.428+5.409
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Devyser Diagnostics AB.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Devyser assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Devyser to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.25 means that Devyser assets are financed with 24.6% credit (debt) and the remaining percentage (100% - 24.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Devyser Diagnostics AB:

  • The MRQ is 0.246. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.247. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.246TTM0.247-0.001
TTM0.247YOY0.192+0.055
TTM0.2475Y0.179+0.068
5Y0.17910Y0.1790.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2460.437-0.191
TTM0.2470.440-0.193
YOY0.1920.359-0.167
5Y0.1790.428-0.249
10Y0.1790.450-0.271
4.5.4.2. Debt to Equity Ratio

Measures if Devyser is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Devyser to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 32.7% means that company has kr0.33 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Devyser Diagnostics AB:

  • The MRQ is 0.327. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.328. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.327TTM0.328-0.001
TTM0.328YOY0.242+0.086
TTM0.3285Y0.226+0.102
5Y0.22610Y0.2260.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3270.640-0.313
TTM0.3280.686-0.358
YOY0.2420.502-0.260
5Y0.2260.666-0.440
10Y0.2260.712-0.486
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Devyser generates.

  • Above 15 is considered overpriced but always compare Devyser to the Diagnostics & Research industry mean.
  • A PE ratio of -22.59 means the investor is paying kr-22.59 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Devyser Diagnostics AB:

  • The EOD is -22.950. Based on the earnings, the company is expensive. -2
  • The MRQ is -22.594. Based on the earnings, the company is expensive. -2
  • The TTM is -25.516. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.950MRQ-22.594-0.356
MRQ-22.594TTM-25.516+2.922
TTM-25.516YOY-24.818-0.698
TTM-25.5165Y-27.992+2.476
5Y-27.99210Y-27.9920.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-22.950-0.356-22.594
MRQ-22.594-0.693-21.901
TTM-25.516-0.881-24.635
YOY-24.818-0.145-24.673
5Y-27.9921.937-29.929
10Y-27.9923.727-31.719
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Devyser Diagnostics AB:

  • The EOD is -31.505. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -31.017. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.962. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-31.505MRQ-31.017-0.488
MRQ-31.017TTM-17.962-13.055
TTM-17.962YOY-12.486-5.476
TTM-17.9625Y-18.411+0.449
5Y-18.41110Y-18.4110.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-31.505-0.676-30.829
MRQ-31.017-1.088-29.929
TTM-17.962-1.123-16.839
YOY-12.486-2.356-10.130
5Y-18.411-2.367-16.044
10Y-18.411-2.248-16.163
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Devyser is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 6.01 means the investor is paying kr6.01 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Devyser Diagnostics AB:

  • The EOD is 6.106. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.011. Based on the equity, the company is overpriced. -1
  • The TTM is 4.735. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD6.106MRQ6.011+0.095
MRQ6.011TTM4.735+1.277
TTM4.735YOY2.871+1.863
TTM4.7355Y3.457+1.278
5Y3.45710Y3.4570.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD6.1062.279+3.827
MRQ6.0112.309+3.702
TTM4.7352.317+2.418
YOY2.8712.384+0.487
5Y3.4573.753-0.296
10Y3.4574.539-1.082
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Depreciation and Amortization  2,6006003,2002,2005,4002005,600-7,700-2,100



6.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets462,900
Total Liabilities114,100
Total Stockholder Equity349,000
 As reported
Total Liabilities 114,100
Total Stockholder Equity+ 349,000
Total Assets = 462,900

Assets

Total Assets462,900
Total Current Assets258,900
Long-term Assets204,000
Total Current Assets
Cash And Cash Equivalents 171,400
Net Receivables 49,500
Inventory 24,600
Other Current Assets 13,400
Total Current Assets  (as reported)258,900
Total Current Assets  (calculated)258,900
+/-0
Long-term Assets
Property Plant Equipment 100,000
Goodwill 6,800
Intangible Assets 76,100
Other Assets 0
Long-term Assets  (as reported)204,000
Long-term Assets  (calculated)182,900
+/- 21,100

Liabilities & Shareholders' Equity

Total Current Liabilities61,500
Long-term Liabilities52,600
Total Stockholder Equity349,000
Total Current Liabilities
Short-term Debt 13,700
Accounts payable 10,100
Other Current Liabilities 37,700
Total Current Liabilities  (as reported)61,500
Total Current Liabilities  (calculated)61,500
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)52,600
Long-term Liabilities  (calculated)0
+/- 52,600
Total Stockholder Equity
Common Stock900
Retained Earnings -187,000
Accumulated Other Comprehensive Income 2,500
Other Stockholders Equity 532,600
Total Stockholder Equity (as reported)349,000
Total Stockholder Equity (calculated)349,000
+/-0
Other
Cash and Short Term Investments 171,400
Common Stock Shares Outstanding 16,484
Liabilities and Stockholders Equity 463,100
Net Debt -157,700
Net Working Capital 197,400
Short Long Term Debt Total 13,700



6.3. Balance Sheets Structured

Currency in SEK. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-31
> Total Assets 
456,867
504,200
505,200
499,400
500,635
486,800
527,100
522,500
510,100
496,600
489,800
462,900
462,900489,800496,600510,100522,500527,100486,800500,635499,400505,200504,200456,867
   > Total Current Assets 
412,657
450,700
442,900
432,800
412,106
394,000
368,500
363,100
341,800
306,000
295,100
258,900
258,900295,100306,000341,800363,100368,500394,000412,106432,800442,900450,700412,657
       Cash And Cash Equivalents 
377,638
412,900
400,800
382,200
363,600
337,400
303,000
287,900
262,900
215,000
201,000
171,400
171,400201,000215,000262,900287,900303,000337,400363,600382,200400,800412,900377,638
       Net Receivables 
26,165
26,100
30,600
38,000
33,382
38,200
41,300
46,700
45,300
52,400
49,200
49,500
49,50049,20052,40045,30046,70041,30038,20033,38238,00030,60026,10026,165
       Inventory 
6,946
8,700
8,900
9,000
10,284
10,600
14,800
15,700
20,600
24,600
26,300
24,600
24,60026,30024,60020,60015,70014,80010,60010,2849,0008,9008,7006,946
       Other Current Assets 
1,908
3,000
2,600
3,600
4,840
7,800
9,400
12,800
13,000
14,000
18,600
13,400
13,40018,60014,00013,00012,8009,4007,8004,8403,6002,6003,0001,908
   > Long-term Assets 
44,210
53,500
62,300
66,600
88,529
92,800
158,600
159,400
168,300
190,600
194,700
204,000
204,000194,700190,600168,300159,400158,60092,80088,52966,60062,30053,50044,210
       Property Plant Equipment 
16,690
17,200
24,000
26,100
30,508
31,800
90,200
90,500
91,500
103,900
102,000
100,000
100,000102,000103,90091,50090,50090,20031,80030,50826,10024,00017,20016,690
       Goodwill 
236
6,300
6,500
6,600
6,766
6,900
7,200
7,000
6,700
7,000
6,900
6,800
6,8006,9007,0006,7007,0007,2006,9006,7666,6006,5006,300236
       Intangible Assets 
0
0
0
0
0
35,600
42,700
43,300
49,400
58,800
64,600
76,100
76,10064,60058,80049,40043,30042,70035,60000000
       Long-term Assets Other 
18,015
22,500
24,400
26,400
32,885
0
-100
-100
0
0
100
0
010000-100-100032,88526,40024,40022,50018,015
> Total Liabilities 
40,184
39,800
53,900
56,700
69,191
73,900
126,700
124,300
125,000
123,100
121,900
114,100
114,100121,900123,100125,000124,300126,70073,90069,19156,70053,90039,80040,184
   > Total Current Liabilities 
29,426
28,100
38,200
41,500
51,233
56,900
55,700
52,200
62,900
64,900
67,100
61,500
61,50067,10064,90062,90052,20055,70056,90051,23341,50038,20028,10029,426
       Short-term Debt 
3,002
3,000
4,200
4,300
5,522
5,600
6,000
5,800
17,500
16,000
14,700
13,700
13,70014,70016,00017,5005,8006,0005,6005,5224,3004,2003,0003,002
       Short Long Term Debt 
0
0
0
0
0
100
100
100
0
100
100
0
0100100010010010000000
       Accounts payable 
9,663
8,000
10,000
10,400
9,602
13,000
12,600
10,300
14,200
17,200
15,000
10,100
10,10015,00017,20014,20010,30012,60013,0009,60210,40010,0008,0009,663
       Other Current Liabilities 
16,527
15,100
21,000
24,200
33,059
32,600
31,500
33,100
30,900
31,000
36,800
37,700
37,70036,80031,00030,90033,10031,50032,60033,05924,20021,00015,10016,527
   > Long-term Liabilities 
10,758
11,700
15,700
15,200
17,958
17,000
71,000
72,100
62,100
58,200
54,800
52,600
52,60054,80058,20062,10072,10071,00017,00017,95815,20015,70011,70010,758
> Total Stockholder Equity
416,683
464,200
451,300
442,700
431,444
412,900
400,300
398,100
385,100
374,500
367,900
349,000
349,000367,900374,500385,100398,100400,300412,900431,444442,700451,300464,200416,683
   Common Stock
872
900
900
900
925
900
900
900
900
900
900
900
900900900900900900900925900900900872
   Retained Earnings -187,000-164,500-142,000-130,200-117,400-111,900-97,400-77,943-61,600-53,000-38,900-33,028
   Accumulated Other Comprehensive Income 
-440
-600
-300
-300
844
1,200
2,300
1,400
1,200
1,700
1,200
2,500
2,5001,2001,7001,2001,4002,3001,200844-300-300-600-440
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
449,279
502,800
503,700
503,700
507,618
508,200
509,000
513,200
513,200
513,900
530,300
532,600
532,600530,300513,900513,200513,200509,000508,200507,618503,700503,700502,800449,279



6.4. Balance Sheets

Currency in SEK. All numbers in thousands.




6.5. Cash Flows

Currency in SEK. All numbers in thousands.




6.6. Income Statements

Currency in SEK. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in SEK. All numbers in thousands.

Gross Profit (+$)
totalRevenue169,300
Cost of Revenue-21,200
Gross Profit148,100148,100
 
Operating Income (+$)
Gross Profit148,100
Operating Expense-204,600
Operating Income-56,500-56,500
 
Operating Expense (+$)
Research Development41,100
Selling General Administrative42,000
Selling And Marketing Expenses121,500
Operating Expense204,600204,600
 
Net Interest Income (+$)
Interest Income5,000
Interest Expense-800
Other Finance Cost-300
Net Interest Income4,500
 
Pretax Income (+$)
Operating Income-56,500
Net Interest Income4,500
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-54,400-58,600
EBIT - interestExpense = -54,400
-54,400
-52,800
Interest Expense800
Earnings Before Interest and Taxes (EBIT)-53,600-53,600
Earnings Before Interest and Taxes (EBITDA)-43,800
 
After tax Income (+$)
Income Before Tax-54,400
Tax Provision--800
Net Income From Continuing Ops-53,600-53,600
Net Income-53,600
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses225,800
Total Other Income/Expenses Net2,100-4,500
 

Technical Analysis of Devyser
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Devyser. The general trend of Devyser is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Devyser's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Devyser Diagnostics AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 141.00 < 141.00.

The bearish price targets are: 120.00 > 116.00 > 116.00.

Tweet this
Devyser Diagnostics AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Devyser Diagnostics AB. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Devyser Diagnostics AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Devyser Diagnostics AB. The current macd is 0.54006259.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Devyser price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Devyser. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Devyser price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Devyser Diagnostics AB Daily Moving Average Convergence/Divergence (MACD) ChartDevyser Diagnostics AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Devyser Diagnostics AB. The current adx is 11.34.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Devyser shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Devyser Diagnostics AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Devyser Diagnostics AB. The current sar is 125.50.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Devyser Diagnostics AB Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Devyser Diagnostics AB. The current rsi is 44.63. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Devyser Diagnostics AB Daily Relative Strength Index (RSI) ChartDevyser Diagnostics AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Devyser Diagnostics AB. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Devyser price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Devyser Diagnostics AB Daily Stochastic Oscillator ChartDevyser Diagnostics AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Devyser Diagnostics AB. The current cci is -92.77964834.

Devyser Diagnostics AB Daily Commodity Channel Index (CCI) ChartDevyser Diagnostics AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Devyser Diagnostics AB. The current cmo is -22.32823353.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Devyser Diagnostics AB Daily Chande Momentum Oscillator (CMO) ChartDevyser Diagnostics AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Devyser Diagnostics AB. The current willr is -82.75862069.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Devyser Diagnostics AB Daily Williams %R ChartDevyser Diagnostics AB Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Devyser Diagnostics AB.

Devyser Diagnostics AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Devyser Diagnostics AB. The current atr is 5.09896662.

Devyser Diagnostics AB Daily Average True Range (ATR) ChartDevyser Diagnostics AB Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Devyser Diagnostics AB. The current obv is -151,235.

Devyser Diagnostics AB Daily On-Balance Volume (OBV) ChartDevyser Diagnostics AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Devyser Diagnostics AB. The current mfi is 64.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Devyser Diagnostics AB Daily Money Flow Index (MFI) ChartDevyser Diagnostics AB Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Devyser Diagnostics AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-14MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Devyser Diagnostics AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Devyser Diagnostics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.635
Ma 20Greater thanMa 50133.475
Ma 50Greater thanMa 100130.400
Ma 100Greater thanMa 200120.510
OpenGreater thanClose130.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Devyser with someone you think should read this too:
  • Are you bullish or bearish on Devyser? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Devyser? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Devyser Diagnostics AB

I send you an email if I find something interesting about Devyser Diagnostics AB.


Comments

How you think about this?

Leave a comment

Stay informed about Devyser Diagnostics AB.

Receive notifications about Devyser Diagnostics AB in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.